Cerevel Therapeutics Holdings (STU:673) Accumulated Depreciation : €-12.88 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cerevel Therapeutics Holdings Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cerevel Therapeutics Holdings's quarterly accumulated depreciation increased from Sep. 2023 (€-10.46 Mil) to Dec. 2023 (€-11.52 Mil) and increased from Dec. 2023 (€-11.52 Mil) to Mar. 2024 (€-12.88 Mil).

Cerevel Therapeutics Holdings's annual accumulated depreciation increased from Dec. 2021 (€-2.27 Mil) to Dec. 2022 (€-6.85 Mil) and increased from Dec. 2022 (€-6.85 Mil) to Dec. 2023 (€-11.52 Mil).

Cerevel Therapeutics Holdings Accumulated Depreciation Historical Data

The historical data trend for Cerevel Therapeutics Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cerevel Therapeutics Holdings Accumulated Depreciation Chart

Cerevel Therapeutics Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

-0.16

-0.07

-2.27

-6.85

-11.52

Cerevel Therapeutics Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial													-7.95	-9.05	-10.46	-11.52	-12.88

Cerevel Therapeutics Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Cerevel Therapeutics Holdings Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Cerevel Therapeutics Holdings's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cerevel Therapeutics Holdings (STU:673) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cerevel Therapeutics Holdings Inc (STU:673) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

CERE:USA

Address

222 Jacobs Street, Suite 200, Cambridge, MA, USA, 02141

Website

https://www.cerevel.com

Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.

Cerevel Therapeutics Holdings (STU:673) Headlines

No Headlines